Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model. (2018)
Attributed to:
FUTURE TARGETED HEALTHCARE MANUFACTURING HUB
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1001/jamaoncol.2018.1901
PubMed Identifier: 29978189
Publication URI: http://europepmc.org/abstract/MED/29978189
Type: Journal Article/Review
Volume: 4
Parent Publication: JAMA oncology
Issue: 11
ISSN: 2374-2437